⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VKTX News
Viking Therapeutics, Inc
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
prnewswire.com
VKTX
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
VKTX
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
prnewswire.com
NVO
ELDN
VKTX
TNDM
Next AI Superchip Sparks Investor Focus on Semiconductor Supply Chain Dynamics
accessnewswire.com
NVDA
ARM
IONQ
RKLB
VKTX
PLTR
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
prnewswire.com
VKTX
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735
prnewswire.com
VKTX
Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek® 2025
prnewswire.com
VKTX
Viking Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com
VKTX
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
prnewswire.com
VKTX